TrialThe AAPS journal2021

Efficacy and Safety Exposure-Response Analysis of Loncastuximab Tesirine in Patients with B cell non-Hodgkin Lymphoma.

Brian Hess et al.PubMed ↗Publisher ↗

No numbers read from the abstract.